Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMIQ20)

Drug Name
Patiromer calcium Drug Info
Synonyms Patiromer; RLY-5016; Potassium binder (hyperkalemia), Relypsa
Indication
Disease Entry ICD 11 Status REF
Hyperkalemia 5C76 Approved [1]
Cross-matching ID
TTD Drug ID
DMMIQ20

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Potassium (K)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sodium zirconium cyclosilicate DMCSLZ4 Hyperkalemia 5C76 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Potassium (K) TTB0SC6 NOUNIPROTAC Binder [2]

References

1 ClinicalTrials.gov (NCT01810939) A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia. U.S. National Institutes of Health.
2 Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8.
3 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.